PPARA and metabolic dysfunction-associated steatohepatitis: Because bilirubin protects the liver by reducing the incidence of nonalcoholic steatohepatitis, which another study showed may progress to cirrhosis and HCC (168, 169), bilirubin may inhibit cancer by binding to PPARα.